申请人:Laevosan-Gesellschaft m.b.H. & Co. KG
公开号:US04590203A1
公开(公告)日:1986-05-20
The disclosure is directed to new derivatives of thiophene-2-carboxylic acid and the pharmaceutically acceptable acid or base addition salts thereof as well as to the process for the preparation thereof. The compounds of the invention have the structural formula ##STR1## in which R in position 3 or 4 of the thiophene nucleus is hydrogen, methyl, chlorine or bromine and R.sub.1 is hydrogen or C.sub.1 -C.sub.4 -alkyl. The compounds have a remarkably strong inhibitory effect on the thromboxane synthetase and are useful for the treatment of conditions such as inflammation, hypertension, thrombus, apoplexy, asthma, angina pectoris, ischemic heart diseases, ischemic conditions, migraine and vascular complications in connection with diabetes.
本公开涉及噻吩-2-羧酸的新衍生物及其药学上可接受的酸或碱盐的制备方法。本发明的化合物具有结构式##STR1##其中,噻吩核的3或4号位的R为氢、甲基、氯或溴,R.sub.1为氢或C.sub.1-C.sub.4烷基。这些化合物具有显著的凝血酶合成酶抑制作用,并可用于治疗炎症、高血压、血栓、中风、哮喘、心绞痛、缺血性心脏病、缺血性病症、偏头痛和与糖尿病相关的血管并发症等疾病。